药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Nilotinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nilotinib.
Flurandrenolide
Dronedarone
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dronedarone.
Flurandrenolide
Temafloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Temafloxacin.
Flurandrenolide
Bepridil
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bepridil.
Flurandrenolide
Halofantrine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Halofantrine.
Flurandrenolide
Berotralstat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Berotralstat.
Flurandrenolide
Emedastine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Emedastine.
Flurandrenolide
Encorafenib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Encorafenib.
Flurandrenolide
Ivosidenib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ivosidenib.
Flurandrenolide
Lenvatinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lenvatinib.
Flurandrenolide
Ceritinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ceritinib.
Flurandrenolide
Crizotinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Crizotinib.
Flurandrenolide
Panobinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Panobinostat.
Flurandrenolide
Pazopanib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Pazopanib.
Flurandrenolide
Dexverapamil
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dexverapamil.
Flurandrenolide
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dexchlorpheniramine.
Flurandrenolide
Lorcainide
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lorcainide.
Flurandrenolide
Bunaftine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bunaftine.
Flurandrenolide
Nizofenone
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nizofenone.
Flurandrenolide
Otilonium
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Otilonium.